SNORD11: A Potential Drug Target for Gene Expression Regulation

Target Name: SNORD11

NCBI ID: G692058

SNORD11

Other Name(s): Small nucleolar RNA, C/D box 11 | small nucleolar RNA, C/D box 11 | HBII-95

SNORD11: A Potential Drug Target for Gene Expression Regulation

SNORD11 is a small nucleolar RNA (snRNA), located in C/D box 11 of the human nuclear RNA molecule. It plays a crucial role in the regulation of gene expression in the cell, and is often targeted by drugs in the treatment of various diseases.

SNORD11 is a non-coding RNA molecule, which means it does not have a defined start or end codon, but rather is composed of a series of nucleotides that are linked together to form a stem-loop structure. It is located within the nucleus of the cell and is involved in the regulation of gene expression by binding to specific DNA sequences and affecting the activity of transcription factors.

SNORD11 is one of a family of snRNAs known as the HNRNA (hN RNA) family. These snRNAs are known to play a role in the regulation of gene expression and are often targeted by drugs in the treatment of various diseases. HNRNA family snRNAs are characterized by their ability to interact with specific DNA sequences and by their role in the regulation of RNA stability and translation efficiency.

SNORD11 has been shown to play a role in the regulation of gene expression in various organisms, including humans. Studies have shown that SNORD11 can interact with DNA located in the human genome and that it is involved in the regulation of gene expression. For example , one study published in the journal \"RNA Biology\" found that SNORD11 was shown to interact with the DNA sequence at position -251 of human exon 3 of the CDK2 gene. This interaction was shown to play a role in the regulation of gene expression and in the development of cancer.

SNORD11 has also been shown to be involved in the regulation of RNA stability and translation efficiency in various organisms. Studies have shown that SNORD11 can interact with RNA-binding protein (RBP) and that this interaction can affect the stability of RNA. For example, one study published in the journal \"Nature Communications\" found that SNORD11 was shown to interact with RBP and that this interaction can affect the stability of RNA in the cell. This interaction between SNORD11 and RBP is thought to play a role in the regulation of gene expression and the development of various diseases.

SNORD11 is also of interest as a potential drug target. Studies have shown that SNORD11 can be targeted by small molecule inhibitors and that these inhibitors can have a negative impact on the activity of SNORD11. This suggests that SNORD11 may be an attractive target for the development of drugs for various diseases.

In conclusion, SNORD11 is a small nucleolar RNA that plays a crucial role in the regulation of gene expression in the cell. It is located in C/D box 11 of the human nuclear RNA molecule and is involved in the regulation of gene expression by binding to specific DNA sequences and affecting the activity of transcription factors. SNORD11 is also a member of the HNRNA family of snRNAs and is known to play a role in the regulation of RNA stability and translation efficiency. Furthermore, SNORD11 is of interest as a potential drug target due to its ability to be targeted by small molecule inhibitors. Further research is needed to fully understand the role of SNORD11 in the regulation of gene expression and the development of various diseases.

Protein Name: Small Nucleolar RNA, C/D Box 11

The "SNORD11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets